Bandingkan Harga & Kinerja Royaltama Mulia Kontraktorindo Tbk. (RMKO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Royaltama Mulia Kontraktorindo Tbk. dan Organon Pharma Indonesia Tbk.: Royaltama Mulia Kontraktorindo Tbk. diperdagangkan di Rp350 (kapitalisasi pasar 561,31 M, volume 24 jam 8,59 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Royaltama Mulia Kontraktorindo Tbk. jauh lebih besar — sekitar 5,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| RMKO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 561,31 M | 104,4 M |
Volume | 8,59 jt | — |
Lot | 85,93 rb | — |
Perputaran | 2,98 M | — |
Harga Rata-rata | 347,35 | — |
Nilai Transaksi | 2,98 M | — |
Harga Ekuilibrium Indikatif | 350 | — |
Volume Ekuilibrium Indikatif | 1,41 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Royaltama Mulia Kontraktorindo Tbk.
PT Royaltama Mulia Kontraktorindo Tbk was established based on Notarial Deed No. 2 datedDecember 18, 2017 of Muhammad Firmansyah, S.H., M.Kn., a public notary in Tangerang. The Company started its commercial operations in 2018.
Selengkapnya di halaman RMKO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
